RAN Yajuan, QIU Sha, QIAN Yan. Effects and Pharmaceutical Care of Antiviral Drugs in the Treatment of COVID-19 on Blood Glucose and Antidiabetic Drugs[J]. 2020,20(5):521-525.
RAN Yajuan, QIU Sha, QIAN Yan. Effects and Pharmaceutical Care of Antiviral Drugs in the Treatment of COVID-19 on Blood Glucose and Antidiabetic Drugs[J]. 2020,20(5):521-525. DOI: 10.14009/j.issn.1672-2124.2020.05.003.
COVID-19 is a kind of infectious disease induced by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection. In response to the infection
the National Health Commission of the People’s Republic of China issued the Diagnostic and Therapeutic Protocol of COVID-19(Trial Seventh Edition)
antiviral drugs including interferon-α
lopinavir/ritonavir
ribavirin
abidol and chloroquine phosphate were recommended. In order to further ensure the safe use of the above drugs in clinical practice
this paper discusses the effects of antiviral drugs on blood glucose and the interaction with antidiabetic drugs in the regimen by referring to relevant literature
and formulates suggestions on pharmaceutical care combined with the pharmacokinetic characteristics and evidence-based evidence.
关键词
新型冠状病毒肺炎抗病毒药血糖药物相互作用药学监护
Keywords
COVID-19Antiviral drugsBlood glucoseDrug interactionPharmaceutical care